Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Celgene Raises Price Of Blood Cancer Drug Revlimid By 4.5%
Celgene Raises Price Of Blood Cancer Drug Revlimid By 4.5%
Celgene Raises Price Of Blood Cancer Drug Revlimid By 4.5%
Submitted by
admin
on December 17, 2010 - 11:36am
Source:
WSJ Online
News Tags:
Revlimid
Celgene
Headline:
Celgene Raises Price Of Blood Cancer Drug Revlimid By 4.5%
Do Not Allow Advertisers to Use My Personal information
